Summary: Human Cloning Ban and Stem Cell Research Protection Act of 2007 - Prohibits: (1) conducting or attempting to conduct human cloning; (2) shipping the product of nuclear transplantation in interstate or foreign commerce for the purpose of human cloning in the United States or elsewhere; or (3) exporting to a foreign country an unfertilized blastocyst if such country does not prohibit human cloning. Sets forth criminal and civil penalties for violations. Requires the Comptroller General to report to the relevant congressional committees on: (1) actions taken to enforce such prohibitions; (2) actions of state attorneys general to enforce similar state laws; (3) coordination of federal, state, and local enforcement; and (4) international laws relating to human cloning. Amends the Public Health Service Act to require research involving nuclear transplantation to be conducted in accordance with applicable federal regulations regarding the protection of human subjects and Institutional Review Boards. Prohibits: (1) a somatic cell nucleus from being transplanted into a human oocyte (egg) that has undergone or will undergo fertilization; (2) an unfertilized blastocyst from being maintained after more than 14 days from its first cell division, not counting storage times at temperatures less than zero degrees centigrade; (3) an oocyte from being used in nuclear transplantation research unless donated voluntarily with the donor's informed consent; (4) a human oocyte or unfertilized blastocyst from being acquired, received, or transferred for valuable consideration in interstate commerce; and (5) nuclear transplantation in a laboratory in which human oocytes are subject to assisted reproductive technology treatments or procedures. Sets forth civil penalties for violations.

human cloning ban stem cell research protection act prohibits conducting attempting conduct human cloning shipping product nuclear transplantation interstate foreign commerce purpose human cloning united_states exporting foreign country country prohibit human cloning sets forth criminal civil penalties violations requires comptroller_general report relevant congressional committees actions taken enforce prohibitions actions state attorneys general enforce similar state laws coordination federal state local enforcement international laws relating human cloning amends public_health_service_act require research involving nuclear transplantation conducted accordance applicable federal regulations protection human subjects institutional review boards prohibits somatic cell human egg undergone undergo fertilization maintained days cell division counting storage times temperatures zero degrees nuclear transplantation research donated voluntarily donor informed consent human acquired received transferred valuable consideration interstate commerce nuclear transplantation laboratory human subject assisted reproductive technology treatments procedures sets forth civil penalties violations


Summary: Safety of Seniors Act of 2007 - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services to: (1) oversee and support a national education campaign focusing on reducing falls among older adults and preventing repeat falls; and (2) award grants, contracts, or cooperative agreements to design and carry out local education campaigns. Allows the Secretary to conduct and support research to: (1) improve the identification of older adults who have a high risk of falling; (2) improve data collection and analysis to identify fall risk and protective factors; (3) design, implement, and evaluate the most effective fall prevention interventions; (4) tailor effective strategies to reduce falls to specific populations of older adults; (5) maximize the dissemination of proven, effective fall prevention interventions; (6) improve the diagnosis, treatment, and rehabilitation of elderly fall victims and older adults at high risk for falls; and (7) assess the risks of falls occurring in various settings. Authorizes the Secretary to: (1) conduct research concerning the barriers to the adoption of proven fall prevention interventions; (2) conduct research to develop, implement, and evaluate the most effective approaches to reduce falls among high-risk older adults living in communities and long-term care and assisted living facilities; (3) evaluate the effectiveness of community programs; (4) provide professional education for physicians and allied health professionals in fall prevention; (5) oversee and support specified demonstration and research projects; (6) award grants to design, implement, and evaluate fall prevention programs using proven intervention strategies and carry out a multistate demonstration project; (7) give priority in awarding grants under this Act to entities that explore the use of cost-sharing to ensure the institutional commitment of the recipients of such assistance to the funded projects; and (8) report to Congress on the effects of falls on health care costs, the potential for reducing falls, and the most effective strategies for reducing associated health care costs.

safety seniors act amends public_health_service_act authorize secretary health_and_human_services oversee support national education campaign focusing reducing falls older adults preventing repeat falls award grants contracts cooperative agreements design carry local education campaigns allows secretary conduct support research improve identification older adults high risk falling improve data collection analysis identify fall risk protective factors design implement evaluate effective fall prevention interventions tailor effective strategies reduce falls specific populations older adults maximize dissemination proven effective fall prevention interventions improve diagnosis treatment rehabilitation elderly fall victims older adults high risk falls assess risks falls occurring settings authorizes secretary conduct research concerning barriers adoption proven fall prevention interventions conduct research develop implement evaluate effective approaches reduce falls high risk older adults living communities long-term_care assisted living facilities evaluate effectiveness community programs provide professional education physicians allied health professionals fall prevention oversee support specified demonstration research projects award grants design implement evaluate fall prevention programs proven intervention strategies carry multistate demonstration project priority awarding grants act entities explore use cost sharing ensure institutional commitment recipients assistance funded projects report congress effects falls health_care costs potential reducing falls effective strategies reducing associated health_care costs


Summary: Alzheimer's Breakthrough Act of 2007 - Title I: Increasing the Federal Commitment to Alzheimer's Research - (Sec. 101) Authorizes appropriations for research on Alzheimer's disease, cognitive health, and related disorders for FY2008-FY2012.(Sec. 102) Amends the Public Health Service Act to require the Director of the National Institute of Aging (the Institute) to continue to make research related to Alzheimer's disease, cognitive health, and related disorders a priority within the Institute's activities consistent with the peer review process.(Sec. 103) Requires the Director to: (1) increase the emphasis on the need to conduct Alzheimer's disease, cognitive health, and related disorder prevention trials within the National Institutes of Health (NIH); and (2) ensure that Alzheimer's disease, cognitive health, and related disorders are maintained as a high priority for the existing neuroscience institute.(Sec. 104) Requires the Secretary of Health and Human Services, acting through the Director, to conduct and support cooperative clinical research regarding Alzheimer's disease, cognitive health, and related disorders. Allows such research to include: (1) investigating therapies, interventions, and agents to detect, treat, slow the progression of, or prevent Alzheimer's disease; (2) enhancing the national infrastructure for the conduct of clinical trials; (3) developing and testing novel approaches to the design and analysis of such trials; and (4) enhancing research currently being done on minorities and health disparities.Requires the Secretary, acting through the Director, to conduct research related to the early detection, diagnosis, and prevention of Alzheimer's disease and of mild cognitive impairment or other potential precursors to Alzheimer's disease. Authorizes such research to include the evaluation of diagnostic tests and imaging techniques.Encourages the Director to explore the feasibility of, and scientific opportunities in, research regarding the prevalence and causes of early onset dementia (dementia diagnosed before the age of 65).Encourages the Secretary, acting through the Director, to conduct research related to the relationship of vascular disease and Alzheimer's disease and related disorders.Requires the Secretary, acting through the Director, to place special emphasis on expediting the translation of research findings into effective treatments and prevention strategies for at-risk individuals.Allows the Secretary, acting through the Director, to establish a National Alzheimer's Coordinating Center to facilitate the collaborative research among Alzheimer's Disease Centers and Alzheimer's Disease Research Centers.Includes outcome measures and disease management within the support provided through Alzheimer's Disease Research Centers. (Sec. 105) Requires the Secretary, acting through the Director, to conduct clinical, social, and behavioral research related to interventions designed to help caregivers of patients with Alzheimer's disease and related disorders and improve patient outcomes.(Sec. 106) Requires the Secretary to: (1) convene a summit every three years on NIH Alzheimer's disease research; and (2) make publicly available information about NIH research, education, and other activities relating to Alzheimer's disease and other related dementias.Title II: Enhanced Public Health Activities Related to Cognitive Health, Alzheimer's Disease and Other Dementias - (Sec. 201) Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to conduct, support, and promote the coordination of research, investigations, demonstrations, training, and studies relating to the control, prevention, and surveillance of the risk factors associated with cognitive health, Alzheimer's disease, and related disorders and to seek early recognition and intervention in the course of Alzheimer's disease and related disorders. Title III: Assistance for Caregivers - (Sec. 301) Requires the Secretary, acting through the Administration on Aging, to award a cooperative grant to a nonprofit or community-based organization to establish and operate an Alzheimer's Call Center to provide expert advice, care consultation, information, and referrals nationwide at the national and local level regarding Alzheimer's disease and related disorders. (Sec. 302) Authorizes appropriations for FY2008-FY2012 for demonstration project grants to states. Expands such grant program to: (1) provide care consultation to individuals with Alzheimer's disease or related disorders who are living in single family homes or in congregate settings; (2) improve the access of such individuals in frontier areas to long-term care services; and (3) encourage grantees to engage in activities related to coordinating long-term care, educating medical personnel, utilizing research, incorporating best practices, and coordinating with Aging and Disability Resource Centers.

alzheimer breakthrough act title increasing federal commitment alzheimer research sec authorizes appropriations research alzheimer disease cognitive health related disorders fy2008 amends public_health_service_act require director national institute aging institute continue research related alzheimer disease cognitive health related disorders priority institute activities consistent peer_review requires director increase emphasis need conduct alzheimer disease cognitive health related disorder prevention trials national_institutes_of_health nih ensure alzheimer disease cognitive health related disorders maintained high priority existing neuroscience requires secretary health_and_human_services acting director conduct support cooperative clinical research alzheimer disease cognitive health related disorders allows research include investigating therapies interventions agents detect treat slow progression prevent alzheimer disease enhancing national infrastructure conduct clinical trials developing testing novel approaches design analysis trials enhancing research currently minorities health disparities requires secretary acting director conduct research related early detection diagnosis prevention alzheimer disease cognitive impairment potential precursors alzheimer disease authorizes research include evaluation diagnostic tests imaging techniques encourages director explore feasibility scientific opportunities research prevalence causes early onset dementia dementia diagnosed age secretary acting director conduct research related relationship vascular disease alzheimer disease related disorders requires secretary acting director place special emphasis expediting translation research findings effective treatments prevention strategies risk individuals allows secretary acting director establish national alzheimer coordinating center facilitate collaborative research alzheimer disease centers alzheimer disease research centers includes outcome measures disease management support provided alzheimer disease research centers sec requires secretary acting director conduct clinical social behavioral research related interventions designed help caregivers patients alzheimer disease related disorders improve patient requires secretary convene summit years nih alzheimer disease research publicly available information nih research education activities relating alzheimer disease related dementias title enhanced public health activities related cognitive health alzheimer disease dementias sec requires secretary acting director centers_for_disease_control_and_prevention cdc conduct support promote coordination research investigations demonstrations training studies relating control prevention surveillance risk factors associated cognitive health alzheimer disease related disorders seek early recognition intervention course alzheimer disease related disorders title iii assistance caregivers sec requires secretary acting administration_on_aging award cooperative grant nonprofit community based organization establish operate alzheimer center provide expert advice care consultation information referrals nationwide national local level alzheimer disease related disorders sec authorizes appropriations fy2008 fy2012 demonstration project grants states expands grant program provide care consultation individuals alzheimer disease related disorders living single family homes congregate settings improve access individuals frontier areas long-term_care services encourage grantees engage activities related coordinating long-term_care educating medical personnel utilizing research incorporating best practices coordinating aging_and_disability_resource_centers


Summary: Amniotic Fluid and Placental Stem Cell Banking Act of 2007 - Directs the Secretary of Health and Human Services to enter into one-time contracts with qualified amniotic fluid and placental stem cell banks to assist in the collection and maintenance of 100,000 new units of high-quality amniotic fluid and placental stem cells to be made available for treatment though the C.W. Bill Young Cell Transplantation and Treatment Program. Sets forth provisions relating to requirements for contract recipients, the duration of such contracts, and extensions of funding under such contracts. Amends the Public Health Service Act to revise the Program to provide for amniotic fluid and placental stem cell functions, recruitment, and educational activities.Authorizes appropriations for the Program through FY2012.

fluid stem cell banking act directs secretary health_and_human_services enter time contracts qualified fluid stem cell banks assist collection maintenance new units high quality fluid stem cells available treatment bill young cell transplantation treatment program sets forth provisions relating requirements contract recipients duration contracts extensions funding contracts amends public_health_service_act revise program provide fluid stem cell functions recruitment educational activities authorizes appropriations program fy2012


Summary: Genomics and Personalized Medicine Act of 2007 - Directs the Secretary of Health and Human Services to: (1) establish the Genomics and Personalized Medicine Interagency Working Group (IWG) to facilitate collaboration, coordination, and integration of activities among federal agencies relating to genomic research and initiatives; (2) establish a national biobanking distributed database for the collection and integration of genomic data and associated environmental and clinical health information; (3) establish a grant program for academic medical centers and other entities to develop or expand biobanking initiatives; (4) improve genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders; (5) contract with the National Academy of Sciences to study incentives to encourage companion diagnostic test development; and (6) make information available on the safety and efficacy of genetic tests and commission a study for improving federal oversight and regulation of such tests. Requires the Director of the Centers for Disease Control and Prevention to: (1) conduct an analysis of the public health impact of direct-to-consumer marketing of genetic tests; and (2) expand efforts to educate the public about genomics and its health applications.

personalized medicine act directs secretary health_and_human_services establish personalized medicine interagency_working_group facilitate collaboration coordination integration activities federal agencies relating research initiatives establish national distributed database collection integration data associated environmental clinical health information establish grant program academic medical centers entities develop expand initiatives improve training diagnosis treatment counseling adults children rare common disorders contract national_academy_of_sciences study incentives encourage companion diagnostic test development information available safety efficacy genetic tests commission study improving federal oversight regulation tests requires director centers_for_disease_control_and_prevention conduct analysis public health impact direct consumer marketing genetic tests expand efforts educate public health applications


Summary: Pediatric Research Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to direct an applicant seeking to waive submission requirements related to pediatric assessments of the safety and effectiveness of a drug or biological product to submit to the Secretary of Health and Human Services documentation detailing why a pediatric formulation cannot be developed. Requires an applicant seeking to defer submission of some or all of such assessments to submit to the Secretary a timeline for the completion of pediatric studies.Requires the Secretary to create an internal committee to review pediatric assessment requests issued, pediatric assessments conducted, and deferral and waiver requests. Considers a supplement to a new drug or biological license application proposing a labeling change as a result of any pediatric assessments to be a priority supplement. Sets forth dispute resolution procedures for labeling changes for pediatric drugs.Requires the Commissioner of the Food and Drug Administration (FDA) to make available to the public the medical, statistical, and clinical pharmacology reviews of pediatric assessments.Requires the Secretary to: (1) require sponsors of the assessments that result in labeling changes to distribute such information to physicians and other health care providers; (2) ensure that all adverse event reports that have been received for such a drug are referred to the Office of Pediatric Therapeutics for one year after a labeling change; and (3) contract with the Institute of Medicine to study and report to Congress regarding the pediatric studies conducted pursuant to FFDCA since 1997.Requires the Comptroller General to report to Congress on the effectiveness of FFDCA provisions relating to pediatric studies in ensuring that medicines used by children are tested and properly labeled.

pediatric research improvement act_-_amends federal food drug cosmetic act ffdca direct applicant seeking waive submission requirements related pediatric assessments safety effectiveness drug biological product submit secretary health_and_human_services documentation detailing pediatric formulation developed requires applicant seeking defer submission assessments submit secretary timeline completion pediatric studies requires secretary create internal committee review pediatric assessment requests issued pediatric assessments conducted deferral waiver requests considers supplement new drug biological license application proposing labeling change result pediatric assessments priority supplement sets forth dispute resolution procedures labeling changes pediatric drugs requires commissioner food_and_drug_administration fda available public medical statistical clinical pharmacology reviews pediatric assessments requires secretary require sponsors assessments result labeling changes distribute information physicians health_care providers ensure adverse event reports received drug referred office_of_pediatric_therapeutics year labeling change contract institute_of_medicine study report congress pediatric studies conducted pursuant ffdca comptroller_general report congress effectiveness ffdca provisions relating pediatric studies ensuring medicines children tested properly labeled


Summary: Stem Cell Research Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements. Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

stem cell research enhancement_act amends public_health_service_act require secretary health_and_human_services conduct support research utilizes human stem cells regardless date stem cells derived human embryo limits research stem cells meet following ethical requirements stem cells derived human donated vitro fertilization clinics purpose fertility treatment excess needs individuals seeking treatment implanted woman individuals donate written informed consent receive financial inducements requires secretary develop techniques isolation production testing stem cells capable producing cell types developing body result improved understanding treatments diseases adverse health conditions derived human embryo requires secretary provide guidance concerning steps required additional research prioritize research greatest potential near term clinical benefit account techniques outlined president council appropriate techniques research


Summary: Human Cloning Prohibition Act of 2007 - Amends the Public Health Service Act to prohibit any person or entity, in or affecting interstate commerce, from knowingly: (1) performing or attempting to perform human cloning; (2) participating in such an attempt; or (3) shipping or receiving an embryo produced by human cloning or any product derived from such an embryo. Prohibits knowingly importing such an embryo. Sets forth criminal and civil penalties. Provides that nothing in this Act restricts areas of scientific research not specifically prohibited, including research in the use of nuclear transfer or other cloning techniques to produce molecules, DNA, cells other than human embryos, tissues, organs, plants, or animals other than humans. Directs the Government Accountability Office (GAO) to assess the need to amend such prohibition, including through: (1) a discussion of new developments, the need for somatic cell transfer to produce medical advances, current public attitudes and prevailing ethical views concerning its use, and potential legal implications of somatic cell transfer research; and (2) a review of any technological developments that may require technical changes to such prohibition.

human cloning prohibition act amends public_health_service_act prohibit person entity affecting interstate commerce knowingly performing attempting perform human cloning participating attempt shipping receiving embryo produced human cloning product derived embryo prohibits knowingly importing embryo sets forth criminal civil penalties provides act restricts areas scientific research specifically prohibited including research use nuclear transfer cloning techniques produce dna cells human tissues organs plants animals humans directs government_accountability_office gao assess need amend prohibition including discussion new developments need somatic cell transfer produce medical advances current public attitudes prevailing ethical views concerning use potential legal implications somatic cell transfer research review technological developments require technical changes prohibition


Summary: Lupus Research, Education, Awareness, Communication, and Healthcare Amendments of 2007 - Amends the Public Health Service Act to require the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to expand research on lupus to include: (1) basic research to discover the pathogenesis and pathophysiology of the disease; and (2) research to validate lupus biomarkers. Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to work with a consortium of academic health institutions to undertake an epidemiological study to determine the prevalence and incidence of lupus in the United States. Requires the Director of CDC to: (1) enter into a cooperative agreement with such consortium to develop, implement, and manage a system for lupus data collection and analysis; and (2) ensure that such consortium represents different geographic areas and includes individuals of racial and ethnic backgrounds disproportionately affected by lupus. Requires the Secretary to enter into a contract with the Institute of Medicine to study and make recommendations related to lupus, to include: (1) evaluating federal and state activities related to lupus and recommending ways to expand such activities; (2) identifying gaps in federal research; and (3) recommending ways to improve the quality of life for people with lupus. Requires the Secretary, acting through the Director of the Office on Women's Health, to conduct and support a national lupus public awareness and health professional education campaign, with an emphasis on reaching populations at highest risk for the disease.

lupus research education awareness communication healthcare amendments amends public_health_service_act require director national institute musculoskeletal skin diseases expand research lupus include basic research discover disease research validate lupus biomarkers requires secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc work consortium academic health institutions undertake epidemiological study determine prevalence incidence lupus united_states requires director cdc enter cooperative agreement consortium develop implement manage system lupus data collection analysis ensure consortium represents different geographic areas includes individuals racial ethnic backgrounds disproportionately affected lupus requires secretary enter contract institute_of_medicine study recommendations related lupus include evaluating federal state activities related lupus recommending ways expand activities identifying gaps federal research recommending ways improve quality life people lupus requires secretary acting director office women health conduct support national lupus public awareness health professional education campaign emphasis reaching populations highest risk disease


Summary: ALS Registry Act - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), if scientifically advisable, to: (1) develop a system to collect data on amyotrophic lateral sclerosis (ALS) and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, or progress to ALS; and (2) establish a national registry for the collection and storage of such data to develop a population-based registry of cases. Authorizes the Secretary, acting through the Director, to establish the Advisory Committee on the National ALS Registry, which may review information and make recommendations to the Secretary concerning: (1) the development and maintenance of the registry; (2) the type of information to be included; (3) the manner in which data is to be collected; (4) the use and availability of such data; and (5) the collection of information about diseases and disorders that primarily affect motor neurons that are considered essential to furthering the study and cure of ALS. Allows the Secretary, acting through the Director, to award grants to, and enter into contracts and cooperative agreements with, public or private nonprofit entities for the collection, analysis, and reporting of data on ALS and other motor neuron disorders. Authorizes the Secretary, acting through the Director, to: (1) identify, build upon, expand, and coordinate among existing data and surveillance systems, surveys, registries, and other federal public health and environmental infrastructure wherever possible; and (2) provide for research access to ALS data as recommended by the Advisory Committee in a manner that protects personal privacy. Allows the Secretary to ensure that epidemiological and other types of information is made available to the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA). (Sec. 3) Authorizes the Secretary to report to the appropriate congressional committees on ALS registries, including: (1) the registries currently under way and future planned registries; (2) the criteria involved in determining what registries to conduct, defer, or suspend; (3) the scope of those registries; and (4) the activities the Secretary undertakes to establish partnerships with research and patient advocacy communities to expand registries.

registry act sec amends public_health_service_act authorize secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc scientifically advisable develop system collect data lateral sclerosis motor disorders progress establish national_registry collection storage data develop population based registry cases authorizes secretary acting director establish advisory_committee national registry review information recommendations secretary concerning development maintenance registry type information included manner data collected use availability data collection information diseases disorders primarily affect motor considered essential furthering study cure allows secretary acting director award grants enter contracts cooperative agreements public private nonprofit entities collection analysis reporting data motor disorders authorizes secretary acting director identify build expand coordinate existing data surveillance systems surveys registries federal public health environmental infrastructure possible provide research access data recommended advisory_committee manner protects personal privacy allows secretary ensure epidemiological types information available national_institutes_of_health nih department_of_veterans_affairs sec authorizes secretary report appropriate congressional committees registries including registries currently way future planned registries criteria involved determining registries conduct defer suspend scope registries activities secretary establish partnerships research patient advocacy communities expand registries


Summary: Inflammatory Bowel Disease Research Enhancement Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with a focus on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; (6) training of qualified health professionals in biomedical research focused on inflammatory bowel disease; and (7) other research priorities identified in specified scientific agendas.Requires the Director of the Centers for Disease Control and Prevention (CDC) to expand the Inflammatory Bowel Disease Epidemiology Program to include additional studies focused on: (1) the incidence and prevalence of pediatric inflammatory bowel disease in the United States; (2) genetic and environmental factors associated with the disease; (3) age, race or ethnicity, gender, and family history of individuals diagnosed with the disease; and (4) treatment approaches and outcomes.

disease research enhancement act_-_requires director national institute diabetes kidney diseases expand intensify coordinate institute research activities disease focus genetic research susceptibility disease research targeted increase knowledge causes complications disease children animal model research clinical research expansion institute disease centers program focus pediatric research training qualified health professionals biomedical research focused disease research priorities identified specified scientific requires director centers_for_disease_control_and_prevention cdc expand disease epidemiology program include additional studies focused incidence prevalence pediatric disease united_states genetic environmental factors associated disease age race ethnicity gender family history individuals diagnosed disease treatment approaches outcomes


Summary: Uterine Fibroid Research and Education Act of 2007 - Requires the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate programs for the conduct and support of uterine fibroids research. Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to develop and disseminate to the public information regarding uterine fibroids, including information on: (1) the incidence and prevalence of uterine fibroids among women; (2) the elevated risk for minority women; and (3) the availability of a range of treatment options. Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA), to develop and disseminate uterine fibroids information to health care providers.

research education act requires director national_institutes_of_health nih expand intensify coordinate programs conduct support research directs secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc develop disseminate public information including information incidence prevalence women elevated risk minority women availability range treatment options requires secretary acting administrator health_resources_and_services_administration hrsa develop disseminate information health_care providers


Summary: Directs the Medical Follow-Up Agency of the Institute of Medicine of the National Academy of Sciences (Agency) to maintain and manage the assets (including electronic data files and biological specimens of study participants) transferred to the Agency from the Air Force Health Study. Authorizes the Agency, during FY2007-FY2011, to conduct additional research on such assets toward the goal of understanding the determinants of health, and promoting wellness, in veterans. Requires an Agency report to Congress assessing the feasibility and advisability of conducting additional research on such assets after the end of FY2011.

directs medical follow agency institute_of_medicine_of_the_national_academy_of_sciences agency maintain manage assets including electronic data files biological specimens study participants transferred agency air_force health study authorizes agency fy2007-fy2011 conduct additional research assets goal understanding determinants health promoting wellness veterans requires agency report congress assessing feasibility advisability conducting additional research assets end fy2011


Summary: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to expand and intensify research and related NIH activities with respect to psoriasis and psoriatic arthritis. Requires the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to conduct or support research to expand understanding of the causes of, and to find a cure for, psoriasis and psoriatic arthritis. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to establish a national psoriasis and psoriatic arthritis patient registry. Directs the Secretary to: (1) enter into cooperative agreements to develop, implement, and manage a system for psoriasis and psoriatic arthritis patient data collection and analysis; (2) ensure the collection and analysis of longitudinal data related to individuals of all ages; (3) convene a summit on current federal activities to conduct or support research, treatment, education, and quality-of-life activities with respect to psoriasis and psoriatic arthritis; and (4) enter into an agreement with the Institute of Medicine to study insurance coverage of psoriasis and psoriatic arthritis.

research cure care act requires secretary health_and_human_services acting director national_institutes_of_health nih expand intensify research related nih activities respect requires director national institute musculoskeletal skin diseases conduct support research expand understanding causes find cure requires secretary acting director centers_for_disease_control_and_prevention cdc establish national patient registry directs secretary enter cooperative agreements develop implement manage system patient data collection analysis ensure collection analysis longitudinal data related individuals ages convene summit current federal activities conduct support research treatment education quality life activities respect enter agreement institute_of_medicine study insurance coverage


Summary: Prostate Research, Imaging, and Men's Education Act or the PRIME Act - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to expand and intensify research to develop advanced imaging technologies for prostate cancer detection, diagnosis, and treatment comparable to mammogram technology.Directs the Secretary: (1) to carry out a national campaign to increase awareness and knowledge with respect to the need for prostate cancer screening and for improved detection technologies; (2) in developing such campaign, to recognize and address the racial disparities in the incidences of prostate cancer and mortality rates; (3) to establish a program to award grants to nonprofit private entities to test alternative outreach and education strategies; (4) to carry out research to develop an improved prostate cancer screening blood test using in-vitro detection; and (5) to certify compliance with this Act within one year.

prostate_research imaging men education act prime act_-_requires secretary health_and_human_services acting director national_institutes_of_health nih expand intensify research develop advanced imaging technologies prostate cancer detection diagnosis treatment comparable mammogram technology directs secretary carry national campaign increase awareness knowledge respect need prostate cancer screening improved detection technologies developing campaign recognize address racial disparities incidences prostate cancer mortality rates establish program award grants nonprofit private entities test alternative outreach education strategies carry research develop improved prostate cancer screening blood test vitro detection certify compliance act year


Summary: SMA Treatment Acceleration Act - Requires the Director of the National Institutes of Health (NIH) to upgrade and unify existing spinal muscular atrophy (SMA) clinical trial sites to establish a national clinical trials network for SMA. Requires the Director of NIH to ensure that such network: (1) conducts coordinated, multisite, clinical trials of pharmacological approaches to the treatment of SMA; and (2) rapidly and effectively disseminates scientific findings to the field.Requires the Director of NIH to: (1) establish an SMA data coordinating center; and (2) expand and intensify NIH programs with respect to preclinical translation research and medicinal chemistry related to SMA.Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enhance and provide ongoing support to the existing SMA patient registry to provide for expanded research on the epidemiology of SMA. Directs the Secretary to ensure the collection and analysis of longitudinal data related to individuals of all ages with SMA.Requires the Secretary to establish the Spinal Muscular Atrophy Coordinating Committee to: (1) coordinate activities across NIH and with other federal health programs and activities relating to SMA; and (2) conduct a study to identify barriers to the development of drugs for treating SMA and similar genetic disorders.Requires the Director of NIH to establish a trans-National Institutes of Health cooperative research initiative on SMA to ensure the success of the SMA projects led by the National Institute of Neurological Disorders and Stroke. Requires the Secretary to submit recommendations to Congress to improve and expand on incentives provided under the Orphan Drug Act and related statutes to promote SMA drug development.

treatment acceleration act_-_requires director national_institutes_of_health nih upgrade existing spinal clinical trial sites establish national clinical trials network requires director nih ensure network conducts coordinated multisite clinical trials pharmacological approaches treatment rapidly effectively disseminates scientific findings field requires director nih establish data coordinating center expand intensify nih programs respect preclinical translation research chemistry related secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc enhance provide ongoing support existing patient registry provide expanded research epidemiology directs secretary ensure collection analysis longitudinal data related individuals ages secretary establish spinal coordinating committee coordinate activities nih federal health programs activities relating conduct study identify barriers development drugs treating similar genetic disorders requires director nih establish trans national_institutes_of_health cooperative research initiative ensure success projects led national institute neurological disorders stroke requires secretary submit recommendations congress improve expand incentives provided orphan drug act related statutes promote drug development


Summary: Family Asthma Act - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to award grants to eligible entities to conduct pilot projects to prevent and control asthma symptoms and to reduce asthma attacks and improve self-management for individuals and families. Requires the Secretary to give: (1) priority to entities that serve a medically underserved population; and (2) consideration to an adequate rural-urban distribution, so as to gain better information about asthma at the national level. Authorizes additional appropriations to the National Heart, Lung, and Blood Institute to develop a National Asthma Action Plan and to fund a report to Congress by the National Asthma Education and Prevention Program. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collaborate with state and local health departments to conduct activities to inform and educate the public regarding asthma; (2) conduct asthma surveillance activities to collect data on the prevalence and severity of asthma, the effectiveness of public heath asthma intervention, and the quality of asthma management; and (3) compile and annually publish asthma data. Requires the Director of the National Institute of Environmental Health Sciences to establish Dr. Irving J. Selikoff individual and institutional training grants for education and training of health care providers on the role of environmental factors in the development and prevention of asthma and recurrent asthma attacks.

family asthma act_-_amends public_health_service_act authorize secretary health_and_human_services acting director national_institutes_of_health nih award grants eligible entities conduct pilot projects prevent control asthma symptoms reduce asthma attacks improve self management individuals families requires secretary priority entities serve medically underserved population consideration adequate rural urban distribution gain better information asthma national level authorizes additional appropriations national_heart lung blood_institute develop national asthma action plan fund report congress national asthma education prevention program requires secretary acting director centers_for_disease_control_and_prevention cdc collaborate state local health departments conduct activities inform educate public asthma conduct asthma surveillance activities collect data prevalence severity asthma effectiveness public heath asthma intervention quality asthma management compile annually publish asthma data requires director national_institute_of_environmental_health_sciences establish individual institutional training grants education training health_care providers role environmental factors development prevention asthma recurrent asthma attacks


Summary: Medical Innovation Prize Act of 2007 - Prohibits any person from having the right to exclusively manufacture, distribute, sell, or use in interstate commerce a drug, a biological product, or a drug or biological product manufacturing process, including the exclusive right to rely on health registration data or the 30-month stay-of-effectiveness period for Orange Book patents under the Federal Food, Drug, and Cosmetic Act, notwithstanding provisions of that Act and other specified laws. Establishes the Fund for Medical Innovation Prizes. Requires the Board of Trustees for the Fund to award prize payments for medical innovations relating to a drug, biological product, or manufacturing process. Requires an eligible award recipient to be either the first person to receive market clearance or the holder of the patent. Directs the Board to consider: (1) the number of patients who benefited from the drug, including non-U.S. patients; (2) the incremental therapeutic benefit of the drug to treat the same disease or condition, except that the Board shall provide for cases where drugs, biological products, or manufacturing processes are developed at roughly the same time so that the comparison is to products that were not recently developed; (3) the degree to which the drug addresses priority health care needs, such as global infectious diseases and neglected diseases that primarily afflict the poor in developing countries; and (4) the improved efficiency of manufacturing processes for drugs or biological processes. Allows the Board to award prize payments for no more than ten years. Allocates certain minimum payments from the Fund for priority research and development.Requires the Comptroller General to conduct an audit to determine the Board's effectiveness in bringing to market new drugs, vaccines, biological products, and manufacturing processes in a cost-effective manner and in addressing society's global medical needs.

medical innovation prize act prohibits person having right exclusively manufacture distribute sell use interstate commerce drug biological product drug biological product manufacturing process including exclusive right rely health registration data month stay effectiveness period orange book patents federal food drug cosmetic act notwithstanding provisions act specified laws establishes fund medical innovation prizes requires board_of_trustees fund award prize payments medical innovations relating drug biological product manufacturing process requires eligible award recipient person receive market clearance holder patent directs board consider number patients benefited drug including non patients incremental therapeutic benefit drug treat disease condition board shall provide cases drugs biological products manufacturing processes developed time comparison products recently developed degree drug addresses priority health_care needs global infectious diseases neglected diseases primarily poor developing countries improved efficiency manufacturing processes drugs biological processes allows board award prize payments years allocates certain minimum payments fund priority research development requires comptroller_general conduct audit determine board effectiveness bringing market new drugs vaccines biological products manufacturing processes cost effective manner addressing society global medical needs


Summary: Amends the Internal Revenue Code to allow a general business tax credit for 50% of expenses paid for research and development of any qualified infectious disease product. Defines "qualified infectious disease product" as any antibiotic drug, antiviral, diagnostic test, biological product, or vaccine developed to treat, detect, prevent, or identify certain pathogens. Terminates such credit after 2012.

amends_the_internal_revenue_code allow general business tax credit expenses paid research development qualified infectious disease product defines qualified infectious disease product antibiotic drug diagnostic test biological product vaccine developed treat detect prevent identify certain pathogens terminates credit


Summary: Catalyst to Better Diabetes Care Act of 2007 - Requires the Secretary of Health and Human Services (the Secretary) to: (1) review uptake and utilization of diabetes screening benefits to identify and address problems with utilization and data collection mechanisms; (2) establish an outreach program to identify existing efforts to increase awareness among seniors and providers of such benefits; and (3) maximize cost-effectiveness in increasing utilization of such benefits.Requires the Secretary of Health and Human Services to establish an advisory group to examine and recommend best practices of employee wellness and disease management programs.Directs the Secretary to prepare, biennially, a diabetes report card for the nation and for each state.Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) promote the education and training of physicians on how to properly complete birth and death certificates and the importance of such data; (2) encourage state adoption of the latest standard revisions of birth and death certificates; and (3) work with states to reengineer their vital statistics systems to provide cost-effective, timely, and vital systems data. Allows the Secretary to promote improvements to the collection of diabetes mortality data.Requires the Secretary to conduct a study of the impact of diabetes on the practice of medicine in the United Sates and the level of diabetes medical education that should be required prior to licensure, board certification, and board recertification.

catalyst better diabetes care act requires secretary health_and_human_services secretary review uptake utilization diabetes screening benefits identify address problems utilization data collection mechanisms establish outreach program identify existing efforts increase awareness seniors providers benefits maximize cost effectiveness increasing utilization benefits requires secretary health_and_human_services establish advisory group examine recommend best practices employee wellness disease management programs directs secretary prepare biennially diabetes report card nation state requires secretary acting director centers_for_disease_control_and_prevention cdc promote education training physicians properly complete birth death certificates importance data encourage state adoption latest standard revisions birth death certificates work states vital statistics systems provide cost effective timely vital systems data allows secretary promote improvements collection diabetes mortality data requires secretary conduct study impact diabetes practice medicine united level diabetes medical education required prior licensure board certification board recertification


Summary: Ovarian Cancer Biomarker Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens.Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee, which shall be established and operated in consultation with the Gynecologic Oncology Group, to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and (3) establish a national data center to conduct statistical analyses of trial data.

cancer research_act amends public_health_service_act require director national_cancer_institute enter cooperative agreements grants public nonprofit entities establish operate centers conduct research biomarkers use risk early detection screening cancer designates center cancer center_of_excellence allows federal payments agreement grant research development characterization new biomarkers refinement existing biomarkers clinical laboratory validation biomarkers development implementation clinical epidemiological research utilization biomarkers development implementation repositories new tissue biological specimens requires director available research tissue specimens clinical research cancer funded department_of_health_and_human_services hhs establish cancer clinical trial committee shall established operated consultation gynecologic group assist director design implement national clinical trials determine utility biomarkers establish national data center conduct statistical analyses trial data


Summary: PEPFAR Accountability and Transparency Act - Amends the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 to direct the Coordinator of United States Government Activities to Combat HIV/AIDS Globally to: (1) establish a mechanism to evaluate global HIV/AIDS programs financed by the U.S. government in order to improve accountability, increase transparency, and ensure the delivery of evidence-based services; and (2) develop a five-year strategic plan for program monitoring, operations research, and impact evaluation research.

accountability transparency act_-_amends united_states_leadership hiv aids tuberculosis malaria_act direct coordinator united_states_government activities combat hiv aids globally establish mechanism evaluate global hiv aids programs financed government order improve accountability increase transparency ensure delivery evidence based services develop year strategic plan program monitoring operations research impact evaluation research


Summary: Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2008 - Amends the Public Health Service Act to designate centers of excellence for research on various forms of muscular dystrophy as Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers. Requires the Muscular Dystrophy Interagency Coordinating Committee to give special consideration to enhancing the clinical research infrastructure required to test emerging therapies for the various forms of muscular dystrophy. Requires the Secretary of Health and Human Services to ensure that any data on patients that is collected as part of the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) is regularly updated to reflect changes in patient condition over time. Requires the Director of the Centers for Disease Control and Prevention (CDC) to: (1) report to the appropriate congressional committees on MD STARnet and data collection; and (2) make publicly available prospective health outcome data on the health and survival of people with muscular dystrophy. Requires the Director of CDC, in carrying out a program to provide information and education on muscular dystrophy to health professionals and the general public, to: (1) partner with leaders in the muscular dystrophy patient community; and (2) widely disseminate the Duchenne-Becker muscular dystrophy care considerations. Requires the Director of the Agency for Healthcare Research and Quality to: (1) evaluate the available scientific evidence to develop and issue an initial set of care considerations for Duchenne-Becker muscular dystrophy and provide ongoing review and updates where appropriate; and (2) replicate the same systematic review methodology used to develop such care considerations as a model for other muscular dystrophies.

paul community assistance research education_amendments amends public_health_service_act designate centers_of_excellence research forms paul cooperative research centers requires interagency_coordinating_committee special consideration enhancing clinical research infrastructure required test emerging therapies forms requires secretary health_and_human_services ensure data patients collected surveillance tracking research network regularly updated reflect changes patient condition time requires director centers_for_disease_control_and_prevention cdc report appropriate congressional committees data collection publicly available prospective health outcome data health survival people requires director cdc carrying program provide information education health professionals general public partner leaders patient community widely disseminate care considerations requires director agency healthcare_research_and_quality evaluate available scientific evidence develop issue initial set care considerations provide ongoing review updates appropriate replicate systematic review methodology develop care considerations model


Summary: Nino's Act - Amends title XIX (Medicaid) of the Social Security Act to provide for mandatory Medicaid coverage of drugs prescribed for certain research study child participants, regardless of Medicaid eligibility otherwise, if the state provides drug coverage.

act_-_amends title xix medicaid social_security_act provide mandatory medicaid coverage drugs prescribed certain research study child participants regardless medicaid eligibility state provides drug coverage


Summary: Ethical Stem Cell Research Tax Credit Act of 2008 - Amends the Internal Revenue Code to allow a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines "qualified stem cell research expenses" as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: (1) the creation of a human embryo for research purposes; (2) the destruction of or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell for prohibited purposes.

ethical stem cell research tax credit act amends_the_internal_revenue_code allow tax credit qualified stem cell research expenses paid incurred taxable year defines qualified stem cell research expenses expenses carrying basic applied research develop techniques isolation production testing human clinical use stem cells result improved understanding treatments diseases adverse health conditions prohibits tax credit research expenses involve creation human embryo research purposes destruction risk injury human embryo use stem cell prohibited purposes


Summary: Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act of 2008 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand and intensify CDC's cancer control programs. Requires the Secretary to: (1) provide guidance to states, in collaboration with the Director of the National Cancer Institute (NCI), on interventions that may be incorporated into state cancer control programs to improve the long-term health status of childhood cancer survivors; (2) encourage states to incorporate strategies for improving their care into their comprehensive cancer plans; (3) collaborate with the NCI Director to improve or develop systems for tracking cancer survivors; and (4) enhance control programs to include a focus on childhood cancer survivorship. Directs the NCI Director to: (1) coordinate National Institutes of Health (NIH) activities regarding cancer survivorship; (2) make grants for research regarding pediatric cancer survivors and health disparities in cancer survivorship within minority populations; (3) conduct or support research to evaluate follow-up care for childhood cancer survivors; and (4) make grants to establish pilot programs to develop, study, or evaluate model systems for monitoring and caring for cancer survivors. Directs the Secretary to make grants to: (1) establish or improve training programs for health care professionals to improve follow-up care for young cancer survivors and to ensure that such care is linguistically and culturally competent; (2) pay costs incurred during the first four years of operating a clinic for comprehensive long-term followup services for childhood cancer survivors; and (3) improve physical and psychosocial care for such survivors.

pediatric adolescent young adult cancer survivorship research quality life act amends public_health_service_act direct secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc expand intensify cdc cancer control programs requires secretary provide guidance states collaboration director national_cancer_institute interventions incorporated state cancer control programs improve long term health status childhood cancer survivors encourage states incorporate strategies improving care comprehensive cancer plans collaborate director improve develop systems tracking cancer survivors enhance control programs include focus childhood cancer survivorship directs director coordinate national_institutes_of_health nih activities cancer survivorship grants research pediatric cancer survivors health disparities cancer survivorship minority populations conduct support research evaluate follow care childhood cancer survivors grants establish pilot programs develop study evaluate model systems monitoring caring cancer survivors directs secretary grants establish improve training programs health_care professionals improve follow care young cancer survivors ensure care linguistically culturally competent pay costs incurred years operating clinic comprehensive long term services childhood cancer survivors improve physical psychosocial care survivors


Summary: Accelerating Cures Act of 2008 - Amends the Public Health Service Act to define "translational research" to mean research that transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical application to reduce disease incidence, morbidity, and mortality.Establishes a Pathways to Cures Subcommittee within the Office of Portfolio Analysis and Strategic Initiatives (OPASI) of the National Institutes of Health (NIH) to help advise and direct translational research priorities.Requires the Director of NIH to establish a Federally Funded Research and Development Center (FFRDC) on clinical effectiveness research. Requires the Director of FFRDC to establish an independent Clinical Effectiveness Advisory Board.Requires the Director of OPASI to appoint a Director of Centralized Institutional Review Boards who shall establish and oversee the functioning and progress of a series of such Boards to serve as human subject safety and well-being custodians for multi-institutional clinical trials that are funded by public research dollars. Requires the Director of NIH to: (1) commission the Institute of Medicine to study the rules that protect patient safety and anonymity; (2) examine informed consent processes; and (3) ensure that each institute and center of NIH has established a translational research training program.Requires the Director of OPASI to develop a Translational Development Program for New Innovations to guide entities through the translational research development process.Establishes the Translational Research Fund to consist of amounts appropriated for translational research priorities.Requires each application for, and summary of, a project, grant, or contract from NIH to include a statement on the possible applications of the research for detecting, treating, or curing a health condition or disease state.

accelerating cures act amends public_health_service_act define translational research mean research scientific discoveries arising laboratory clinical population studies clinical application reduce disease incidence morbidity mortality establishes pathways cures subcommittee office portfolio analysis strategic initiatives national_institutes_of_health nih help advise direct translational research priorities requires director nih establish federally funded research development center ffrdc clinical effectiveness research requires director ffrdc establish independent clinical effectiveness advisory_board requires director appoint director centralized institutional review boards shall establish oversee functioning progress series boards serve human subject safety multi institutional clinical trials funded public research dollars requires director nih commission institute_of_medicine study rules protect patient safety examine informed consent processes ensure institute center nih established translational research training program requires director develop translational development program new innovations guide entities translational research development process establishes translational research fund consist amounts appropriated translational research priorities requires application summary project grant contract nih include statement possible applications research detecting treating curing health condition disease state


Summary: National Neurotechnology Initiative Act - Defines "neurotechnology" to mean the science and technology that allows an individual to analyze, understand, treat, and heal the brain and nervous system.Requires the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, under which the Secretary shall: (1) establish goals, priorities, and metrics for evaluation for federal neurotechnology research, development, and commercialization; (2) increase the investment in federal research, development, and translational programs in neurotechnology to achieve such goals; and (3) increase interagency coordination.Requires the Secretary to establish the National Neurotechnology Coordination Office and the National Neurotechnology Advisory Council.Requires the Director of the National Institutes of Health (NIH) to develop the Blueprint for Neuroscience Research to: (1) identify pervasive challenges in neuroscience and any technological barriers to solving such challenges; and (2) support the development of new tools, training opportunities, and other resources to assist neuroscientists in basic and clinical research. Directs the Commissioner of Food and Drugs to require the Directors of the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health to improve the timelines of the review process for neurology and psychiatry.Requires the Director of the National Neurotechnology Coordination Office to establish the American Neurotechnology Study Center.

national initiative act defines mean science_and_technology allows individual analyze understand treat heal brain nervous system requires secretary health_and_human_services implement national initiative secretary shall establish goals priorities metrics evaluation federal research development commercialization increase investment federal research development translational programs achieve goals increase interagency coordination requires secretary establish national coordination office national advisory_council requires director national_institutes_of_health nih develop neuroscience research identify pervasive challenges neuroscience technological barriers solving challenges support development new tools training opportunities resources assist basic clinical research directs commissioner food_and_drugs require directors center_for_drug_evaluation_and_research center_for_biologics_evaluation_and_research center_for_devices_and_radiological_health improve timelines review process psychiatry requires director national coordination office establish american study center


Summary: Cure and Understanding through Research for Alzheimer's Act of 2008 or the Cura Act of 2008 - Requires the Director of the National Institutes of Health (NIH) to ensure sufficient resources for activities relating to Alzheimer's disease and Hispanic communities, including by: (1) increasing efforts in epidemiological work in Hispanic subgroups; (2) allocating resources to the National Institute on Aging Alzheimer's disease research centers and other academic centers involved in such research to increase participation of Hispanics and other underrepresented ethnic groups in research and clinical trials in sufficient numbers to draw valid conclusions; and (3) conducting social, behavioral, and health services research to understand the underlying reasons why Hispanic individuals delay diagnosis and underutilize services, to identify culturally and linguistically appropriate approaches to address such delays and underutilization, and to identify what is culturally competent care.Requires the Director to expand and intensify NIH efforts to educate communities about the importance of research relating to Alzheimer's disease and to respond effectively to cultural concerns about participation in such research.Amends the Public Health Service Act to authorize appropriations for a program of grants to states to carry out demonstration programs related to Alzheimer's disease.Requires the Secretary of Health and Human Services, acting through the Centers for Disease Control and Prevention (CDC), to conduct an aggressive, evidence-based education and outreach program to promote public awareness and risk reduction with respect to Alzheimer's disease, particularly to Hispanic populations.

cure understanding research alzheimer act act requires director national_institutes_of_health nih ensure sufficient resources activities relating alzheimer disease hispanic communities including increasing efforts epidemiological work hispanic subgroups allocating resources national institute aging alzheimer disease research centers academic centers involved research increase participation underrepresented ethnic groups research clinical trials sufficient numbers draw valid conclusions conducting social behavioral health services research understand underlying reasons hispanic individuals delay diagnosis services identify culturally linguistically appropriate approaches address delays identify culturally competent care requires director expand intensify nih efforts educate communities importance research relating alzheimer disease respond effectively cultural concerns participation research amends public_health_service_act authorize appropriations program grants states carry demonstration programs related alzheimer disease requires secretary health_and_human_services acting centers_for_disease_control_and_prevention cdc conduct aggressive evidence based education outreach program promote public awareness risk reduction respect alzheimer disease particularly hispanic populations


Summary: Financial Market Investigation, Oversight, and Reform Act of 2008 - Establishes the Commission on Financial Regulatory Reform to review the nation's existing financial regulatory structure and its contribution to the stability or instability of financial markets. Requires the Commission to review: (1) bank holding companies, financial holding companies, commercial banks, investment banks, thrifts, credit unions, and industrial loan companies; (2) payment and settlement systems; (3) hedge funds, private equity funds, and markets for alternative investments; (4) special purpose vehicles and off-balance sheet financing for financial companies; (5) securitization of mortgages and other assets; (6) exchange-based, electronic, and over-the-counter markets for financial derivative products; (7) the mortgage finance industry, including mortgage brokers and mortgage lending institutions; (8) equity markets, including short-selling practices, and commodity futures markets; and (8) the insurance industry and its role in the financial markets.Requires the Commission to report to the President and Congress on its findings and recommendations for corrective measures. Establishes a multidisciplinary Joint Select Committee on Financial Market Oversight Reform and Investigations to investigate the causes of the financial turmoil and propose corrective actions to the appropriate committees of jurisdiction. Establishes the Office of the Inspector General for Financial Markets Oversight to: (1) conduct, supervise, and coordinate investigations into whether ethics violations or conflicts of interest between regulators and their regulated entities or markets may have affected agency decision-making between January 2002 and August 2008; and (2) use the forum of the President's Council on Integrity and Efficiency and the Executive Council on Integrity and Efficiency to share findings and best practices with regards to ethics, conflicts of interest, oversight, and accountability.

financial market investigation oversight reform_act establishes_the_commission financial regulatory reform review nation existing financial regulatory structure contribution stability instability financial markets requires commission review bank holding companies financial holding companies commercial banks investment banks credit unions industrial loan companies payment settlement systems hedge funds private equity funds markets alternative investments special purpose vehicles balance sheet financing financial companies securitization mortgages assets exchange based electronic counter markets financial derivative products mortgage finance industry including mortgage brokers mortgage lending institutions equity markets including short selling practices commodity futures markets insurance industry role financial markets requires commission report president congress findings recommendations corrective measures establishes multidisciplinary joint_select_committee financial market oversight reform investigations investigate causes financial propose corrective actions appropriate committees jurisdiction establishes office_of_the_inspector_general financial markets oversight conduct supervise coordinate investigations ethics violations conflicts interest regulators regulated entities markets affected agency decision making january august use forum president council integrity efficiency executive council integrity efficiency share findings best practices regards ethics conflicts interest oversight accountability


Summary: Research, Hazard Intervention, and National Outreach for Healthier Homes Act of 2008 - Directs the Director of the National Institute of Environmental Health Sciences and the Administrator of the Environmental Protection Agency (EPA) to evaluate the health effects of housing-related health hazards for which limited research or understanding of causes or associations exists. Directs the Secretary of Housing and Urban Development (HUD) to implement studies by the Office of Healthy Homes and Lead Hazard Control of the assessment, prevention, and control of housing-related health hazards. Directs the Administrator of the EPA to study how sustainable building features in existing housing affect the quality of the indoor environment, the prevalence of housing-related health hazards, and the health of occupants. Directs the Secretary of HUD to complete the analysis of data collected for the National Survey on Lead and Allergens in Housing and the American Healthy Housing Survey. Directs the Administrator of the EPA to expand current indoor environmental monitoring efforts to establish baseline levels of indoor chemical pollutants and their sources. Requires the Director of the Centers for Disease Control and Prevention (CDC) to determine the data and resources needed to establish a healthy housing data collection system. Directs the Secretary of HUD to: (1) develop improved methods for evaluating, reducing, and preventing health hazards in housing; (2) support development of objective measures for a healthy residential environment; (3) promote the incorporation of healthy housing principles in post-disaster environments as well as ongoing practices and systems, and of health considerations into green and energy-efficient construction and rehabilitation; (4) improve the dissemination of healthy housing information; and (5) promote state and local level healthy housing efforts. Amends the Public Health Service Act with respect to the CDC Program Capacity on Housing-Related Health Hazard. Directs the Administrator of the EPA, acting through the director of the Office of Children's Health Protection and Environmental Education, to address health hazards in the home environment, with particular attention to children, the elderly, and families with limited resources. Directs the Secretary of HUD to award health hazard reduction grants to reduce significant structural, health, and safety hazards in the home. Directs the Secretary of Agriculture, acting through the Cooperative State Research, Education, and Extension Service, to establish a competitive grant program to promote education and outreach on housing-related health hazards. Amends the Housing and Community Development Act of 1992 with respect to enforcement of the lead disclosure rule. Establishes within the EPA voluntary products and materials and housing labeling programs. Specifies the duties of the EPA Administrator with respect to the Healthy Home Seal of Approval. Directs the EPA Administrator to provide public education and outreach on environmental health risks experienced by the elderly, and low-cost methods for addressing them. Directs the Secretary of HUD to award funds for a Health Hazards Outreach competitive grant program. Directs the Secretary of HUD, the Director of the CDC, and the Administrator of the EPA to establish a national healthy housing media campaign.

research hazard intervention national outreach healthier homes act directs director national_institute_of_environmental_health_sciences administrator environmental_protection_agency epa evaluate health effects housing related health hazards limited research understanding causes associations exists directs secretary housing_and_urban_development hud implement studies office healthy homes lead hazard control assessment prevention control housing related health hazards directs administrator epa study sustainable building features existing housing affect quality indoor environment prevalence housing related health hazards health occupants directs secretary hud complete analysis data collected national survey lead housing american healthy housing survey directs administrator epa expand current indoor environmental monitoring efforts establish baseline levels indoor chemical pollutants sources requires director centers_for_disease_control_and_prevention cdc determine data resources needed establish healthy housing data collection system directs secretary hud develop improved methods evaluating reducing preventing health hazards housing support development objective measures healthy residential environment promote incorporation healthy housing principles post disaster environments ongoing practices systems health considerations green energy efficient construction rehabilitation improve dissemination healthy housing information promote state local level healthy housing efforts amends public_health_service_act respect cdc program capacity housing related health hazard directs administrator epa acting director office children health protection environmental education address health hazards home environment particular attention children elderly families limited resources directs secretary hud award health hazard reduction grants reduce significant structural health safety hazards home directs secretary agriculture acting cooperative state research education extension_service establish competitive grant program promote education outreach housing related health hazards amends housing_and_community_development_act respect enforcement lead disclosure rule establishes epa voluntary products materials housing labeling programs specifies duties epa administrator respect healthy home seal approval directs epa administrator provide public education outreach environmental health risks experienced elderly low cost methods addressing directs secretary hud award funds health hazards outreach competitive grant program directs secretary hud director cdc administrator epa establish national healthy housing media campaign


Summary: Federal Ocean Acidification Research And Monitoring Act of 2009 or FOARAM Act - Defines "ocean acidification," for this Act, as the decrease in pH of the Earth's oceans and changes in ocean chemistry caused by chemical inputs from the atmosphere, including carbon dioxide. Requires the Joint Subcommittee on Ocean Science and Technology of the National Science and Technology Council to develop a strategic plan for federal ocean acidification research and monitoring that provides for an assessment of ocean acidification impacts on marine organisms and ecosystems and the development of adaptation and mitigation strategies to conserve marine organisms and ecosystems. Directs the Secretary of Commerce to conduct research and monitoring and authorizes the Secretary to establish an ocean acidification program in the National Oceanic and Atmospheric Administration (NOAA) consistent with the strategic research plan, including: (1) providing grants for critical research projects exploring the effects of ocean acidification on ecosystems and the socioeconomic impacts of increased ocean acidification; and (2) incorporating a competitive merit-based process for awarding grants that may be conducted jointly with other participating agencies or under the National Oceanographic Partnership Program. Requires the National Science Foundation (NSF) director to continue to carry out ocean acidification research supporting competitive, merit-based, peer-reviewed proposals for research and monitoring of ocean acidification and its impacts. Requires the administrator of the National Aeronautics and Space Administration (NASA) to ensure that space-based monitoring assets are used in as productive a manner as possible for monitoring of ocean acidification and its impacts.

federal ocean acidification research monitoring act act defines ocean acidification act decrease earth oceans changes ocean chemistry caused chemical inputs atmosphere including carbon dioxide requires joint subcommittee ocean science_and_technology national_science_and_technology_council develop strategic plan federal ocean acidification research monitoring provides assessment ocean acidification impacts marine organisms ecosystems development adaptation mitigation strategies conserve marine organisms ecosystems directs secretary commerce conduct research monitoring authorizes secretary establish ocean acidification program national_oceanic_and_atmospheric_administration noaa consistent strategic research plan including providing grants critical research projects exploring effects ocean acidification ecosystems socioeconomic impacts increased ocean acidification incorporating competitive merit based process awarding grants conducted jointly participating agencies national oceanographic partnership program requires national_science_foundation nsf director continue carry ocean acidification research supporting competitive merit based peer reviewed proposals research monitoring ocean acidification impacts requires administrator national_aeronautics_and_space_administration nasa ensure space based monitoring assets productive manner possible monitoring ocean acidification impacts


Summary: Melanie Blocker Stokes Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act or the Melanie Blocker Stokes MOTHERS Act - Title I: Research on Postpartum Conditions - (Sec. 101) Encourages the Secretary of Health and Human Services to continue: (1) activities on postpartum depression; and (2) research to expand the understanding of the causes of, and treatments for, postpartum conditions. (Sec. 102) Expresses the sense of Congress that the Director of the National Institute of Mental Health may conduct a nationally representative longitudinal study of the relative mental health consequences for women of resolving a pregnancy in various ways, including carrying the pregnancy to term and parenting the child, carrying the pregnancy to term and placing the child for adoption, miscarriage, and having an abortion. Title II: Delivery of Services Regarding Postpartum Conditions - (Sec. 201) Amends the Public Health Service Act to authorize the Secretary to make grants for projects for the establishment, operation, and coordination of effective and cost-efficient systems for the delivery of essential services to individuals with a postpartum condition and their families. Directs the Secretary to ensure that such projects provide education and services with respect to the diagnosis and management of postpartum conditions. Authorizes such projects to include: (1) delivering or enhancing outpatient home-based health and support services; and (2) providing education to new mothers and their families about postpartum conditions to promote earlier diagnosis and treatment. Sets forth grant requirements. Authorizes the Secretary to provide technical assistance to entities seeking a grant. Title III: General Provisions - (Sec. 301) Authorizes appropriations for FY2010-FY2012. (Sec. 302) Directs the Secretary to study and report to Congress on the benefits of screening for postpartum conditions. (Sec. 303) Prohibits the Secretary from utilizing amounts appropriated under this Act to carry out activities or programs that are duplicative of activities or programs that are already being carried out through the Department of Health and Human Services (HHS).

mom opportunity access health education research support postpartum depression act mothers act title research postpartum conditions sec encourages secretary health_and_human_services continue activities postpartum depression research expand understanding causes treatments postpartum conditions sec expresses sense congress director national_institute_of_mental_health conduct nationally representative longitudinal study relative mental health consequences women resolving pregnancy ways including carrying pregnancy term parenting child carrying pregnancy term placing child adoption having abortion title delivery services postpartum conditions sec amends public_health_service_act authorize secretary grants projects establishment operation coordination effective cost efficient systems delivery essential services individuals postpartum condition families directs secretary ensure projects provide education services respect diagnosis management postpartum conditions authorizes projects include delivering enhancing outpatient home based health support services providing education new mothers families postpartum conditions promote earlier diagnosis treatment sets forth grant requirements authorizes secretary provide technical assistance entities seeking grant title iii general_provisions sec authorizes appropriations fy2010 fy2012 sec directs secretary study report congress benefits screening postpartum conditions sec prohibits secretary utilizing amounts appropriated act carry activities programs duplicative activities programs carried department_of_health_and_human_services hhs


Summary: Human Cloning Prohibition Act of 2009 - Amends the federal criminal code to prohibit any public or private person or entity, in or affecting interstate commerce, from: (1) performing or attempting to perform human cloning; (2) participating in an attempt to perform human cloning; or (3) shipping, receiving, or importing the product of human cloning for any purpose. Sets forth criminal and civil penalties for violations.Provides that nothing in this Act shall restrict areas of scientific research not specifically prohibited by this Act, including research in the use of nuclear transfer or other cloning techniques to produce molecules, DNA, cells other than human embryos, tissues, organs, plants, or animals other than humans.

human cloning prohibition act amends federal criminal code prohibit public private person entity affecting interstate commerce performing attempting perform human cloning participating attempt perform human cloning shipping receiving importing product human cloning purpose sets forth criminal civil penalties violations provides act shall restrict areas scientific research specifically prohibited act including research use nuclear transfer cloning techniques produce dna cells human tissues organs plants animals humans


Summary: National Hurricane Research Initiative Act of 2009 - Requires the Under Secretary for Oceans and Atmosphere of the Department of Commerce and the Director of the National Science Foundation (NSF) to establish a National Hurricane Research Initiative and to cooperate with other specified federal agencies to carry it out. Requires such Initiative to set research objectives (based on a National Science Board report on the need for such Initiative) to: (1) make recommendations to the Board and to the National Oceanic and Atmospheric Administration (NOAA) Science Advisory Board; (2) assemble the science and engineering expertise of state or local government agencies and nongovernmental entities through a multi-agency effort focused on improving severe tropical storm forecasting capabilities, on durable and resilient infrastructure, and on mitigating impacts on coastal populations, the coastal built environment, and the natural coastal environment; and (3) make grants for hurricane research, including regarding storm internal dynamics, predicting high winds, tornadoes, and storm surge, and improving measurements of hurricanes and tropical storms through specified technologies.Directs the White House Office of Science and Technology Policy, through the National Science and Technology Council, to coordinate U.S. activities related to the Initiative as a formal program with a well-defined organizational structure and execution plan. Directs the Under Secretary and the Director to: (1) issue a request for proposals to undertake the basic and applied research with a sufficient annual budget to accomplish the desired research results during a 10-year term; (2) establish a National Infrastructure Database; and (3) develop a National Hurricane Research Model.

national hurricane research initiative act requires secretary oceans atmosphere department_of_commerce director national_science_foundation nsf establish national hurricane research initiative cooperate specified federal agencies carry requires initiative set research objectives based national_science_board report need initiative recommendations board national_oceanic_and_atmospheric_administration noaa science_advisory_board assemble science engineering expertise state local government agencies nongovernmental entities multi agency effort focused improving severe tropical storm forecasting capabilities durable resilient infrastructure mitigating impacts coastal populations coastal built environment natural coastal environment grants hurricane research including storm internal dynamics predicting high storm surge improving measurements hurricanes tropical storms specified technologies directs white_house office_of_science_and_technology_policy national_science_and_technology_council coordinate activities related initiative formal program defined organizational structure execution plan directs secretary director issue request proposals undertake basic applied research sufficient annual budget accomplish desired research results year term establish national infrastructure database develop national hurricane research model


Summary: Pediatric Research Consortia Establishment Act - Amends the Public Health Service Act to authorize the Director of the National Institutes of Health (NIH), acting through the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, to award grants, contracts, or cooperative agreements to public or nonprofit private entities to pay all or part of the cost of planning, establishing, and providing basic operating support for up to 20 national pediatric research consortia. Requires the Director of NIH to take unmet research needs into account when making awards under this Act. Declares that research conducted under this Act shall supplement, but not replace, research that is otherwise conducted or supported as part of the comprehensive pediatric research portfolio. Requires consortia to conduct basic, clinical, behavioral, social, or translational research, as well as training in, and demonstration of, advanced diagnostic and treatment methods relating to pediatrics. Requires the Director of NIH to: (1) provide for the coordination of information and ensure regular communication between consortia; and (2) require periodic reports on the activities of the consortia. Requires each consortium under this Act to be formed from a collaboration of cooperating institutions with a lead institution, meeting requirements that may be prescribed by the Director of NIH. Declares that payments made under this Act may be provided for a period of five years and extended for additional five-year periods with enhanced funding opportunities based on an appropriate scientific review of the operations.

pediatric research consortia establishment act_-_amends public_health_service_act authorize director national_institutes_of_health nih acting director eunice kennedy shriver national institute child health human development award grants contracts cooperative agreements public nonprofit private entities pay cost planning establishing providing basic operating support national pediatric research consortia requires director nih unmet research needs account making awards act declares research conducted act shall supplement replace research conducted supported comprehensive pediatric research portfolio requires consortia conduct basic clinical behavioral social translational research training demonstration advanced diagnostic treatment methods relating pediatrics requires director nih provide coordination information ensure regular communication consortia require periodic reports activities consortia requires consortium act formed collaboration cooperating institutions lead institution meeting requirements prescribed director nih declares payments act provided period years extended additional year periods enhanced funding opportunities based appropriate scientific review operations